An Amphipathic Structure of a Dipropylglycine-Containing Helical Peptide with Sufficient Length Enables Safe and Effective Intracellular siRNA Delivery
Chemical and Pharmaceutical Bulletin · 01.03.2023 · 71 (3) · 250-256
DOI: 10.1248/cpb.c22-00852 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical and Pharmaceutical Bulletin, erschienen am 01.03.2023. Verfasst von Makoto Oba und 6 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Medical Science, Kyoto Prefectural University of Medicine. Hauptthemen laut MEDLINE: Valine, Cell-Penetrating Peptides. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School of Medical Science, Kyoto Prefectural University of Medicine.
- Graduate School of Biomedical Sciences, Nagasaki University.
Zitieren
APA
Oba, M., Shibuya, M., Yamaberi, Y., Yokoo, H., Uchida, S., Ueda, A., & Tanaka, M. (2023). An Amphipathic Structure of a Dipropylglycine-Containing Helical Peptide with Sufficient Length Enables Safe and Effective Intracellular siRNA Delivery. Chemical and Pharmaceutical Bulletin, 71(3), 250-256. https://doi.org/10.1248/cpb.c22-00852
Vancouver
Oba M, Shibuya M, Yamaberi Y, Yokoo H, Uchida S, Ueda A, et al. An Amphipathic Structure of a Dipropylglycine-Containing Helical Peptide with Sufficient Length Enables Safe and Effective Intracellular siRNA Delivery. Chemical and Pharmaceutical Bulletin. 2023;71(3):250-256. doi:10.1248/cpb.c22-00852
BibTeX
@article{Oba2023,
author = {Oba, Makoto and Shibuya, Mika and Yamaberi, Yuto and Yokoo, Hidetomo and Uchida, Satoshi and Ueda, Atsushi and Tanaka, Masakazu},
title = {An Amphipathic Structure of a Dipropylglycine-Containing Helical Peptide with Sufficient Length Enables Safe and Effective Intracellular siRNA Delivery},
journal = {Chemical and Pharmaceutical Bulletin},
year = {2023},
volume = {71},
number = {3},
pages = {250--256},
doi = {10.1248/cpb.c22-00852}
}
EUVIMED